Animal models of colitis-associated carcinogenesis

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Mizoguchi, Emiko ^a   Kanneganti, Manasa ^a   Mino Kenudson, Mari ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APC PROTEIN; CALCIUM; CARCINOGEN; CARRAGEENAN; CELECOXIB; CHITINASE; DEXTRAN SULFATE; ENDOTHELIAL CELL GROWTH FACTOR; ETANERCEPT; GLYCOPROTEIN GP 39; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; IRON; NATALIZUMAB; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROTEIN MSH2; PROTEIN P53; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADENOMATOUS POLYP; ARTICLE; BLADDER CANCER; CALCIUM INTAKE; CANCER PREVENTION; CANCER RISK; CHEMICALLY INDUCED DISORDER; CHROMOSOMAL INSTABILITY; CHRONIC DISEASE; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CROHN DISEASE; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; HUMAN; KNOCKOUT MOUSE; MEDIATOR RELEASE; NONHUMAN; RHEUMATOID ARTHRITIS; ANIMAL; CALLITRICHINAE; COLON TUMOR; DISEASE MODEL; ENTERITIS; MOUSE; PATHOLOGY; REVIEW; TRANSGENIC ANIMAL;

ANIMALIA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CALLITRICHINAE; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE;

EID: 79952224171     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/342637     Document Type: Article

References (240)

1. Crohn B., Rosenberg H., The sigmoidoscopic picture of chronic ulcerative colitis (non-specific) American Journal of the Medical Sciences 1925 170 220 228
2. Eaden J. A., Abrams K. R., Mayberry J. F., The risk of colorectal canc (Pubitemid 32234798)
3. Kornfeld D., Ekbom A., Ihre T., Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study Gut 1997 41 4 522 525
4. Vera A., Gunson B. K., Ussatoff V., Nightingale P., Candinas D., Radley S., Mayer A. D., Buckels J. A. C., McMaster P., Neuberger J., Mirza D. F., Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis Transplantation 2003 75 12 1983 1988 (Pubitemid 36793279)
5. Lakatos L., Mester G., Erdelyi Z., David G., Pandur T., Balogh M., Fischer S., Vargha P., Lakatos P. L., Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study Inflammatory Bowel Diseases 2006 12 3 205 211
6. Willenbucher R. F., Zelman S. J., Ferrell L. D., Moore D. H. 2nd, Waldman F. M., Chromosomal alterations in ulcerative colitis-related neoplastic progression Gastroenterology 1997 113 3 791 801 (Pubitemid 27381138)
7. Byers T., Levin B., Rothenberger D., Dodd G. D., Smith R. A., American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997 Ca-A Cancer Journal for Clinicians 1997 47 3 154 160 (Pubitemid 27226282)
8. Kulaylat M. N., Dayton M. T., Ulcerative colitis and cancer Journal of Surgical Oncology 2010 101 8 706 712
9. Podolsky D. K., Mucosal immunity and inflammation V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense American Journal of PhysiologyGastrointestinal and Liver Physiology 1999 277 3 G495 G499
10. Hooper L. V., Wong M. H., Thelin A., Hansson L., Falk P. G., Gordon J. I., Molecular analysis of commensal host-microbial relationships in the intestine Science 2001 291 5505 881 884 (Pubitemid 32120760)
11. Wilson C. L., Ouellette A. J., Satchell D. P., Ayabe T., Lpez-Boado Y. S., Stratman J. L., Hultgren S. J., Matrisian L. M., Parks W. C., Regulation of intestinal -defensin activation by the metalloproteinase matrilysin in innate host defense Science 1999 286 5437 113 117 (Pubitemid 29484488)
12. Higgins L. M., Frankel G., Connerton I., Gonalves N. S., Dougan G., MacDonald T. T., Role of bacterial intimin in colonic hyperplasia and inflammation Science 1999 285 5427 588 591
13. Roediger W. E. W., Babidge W., Human colonocyte detoxification Gut 1997 41 6 731 734 (Pubitemid 28023172)
14. Mizoguchi E., Xavier R. J., Reinecker H. C., Uchino H., Bhan A. K., Podolsky D. K., Mizoguchi A., Colonic epithelial functional phenotype varies with type and phase of experimental colitis Gastroenterology 2003 125 1 148 161 (Pubitemid 36799116)
15. Levitt M. D., Furne J., Springfield J., Suarez F., DeMaster E., Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa Journal of Clinical Investigation 1999 104 8 1107 1114 (Pubitemid 29536321)
16. Mizoguchi E., Mizoguchi A., Takedatsu H., Cario E., De Jong Y. P., Ooi C. J., Xavier R. J., Terhorst C., Podolsky D. K., Bhan A. K., Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice Gastroenterology 2002 122 1 134 144 (Pubitemid 34049202)
17. Cario E., Rosenberg I. M., Brandwein S. L., Beck P. L., Reinecker H. C., Podolsky D. K., Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors Journal of Immunology 2000 164 2 966 972 (Pubitemid 30043724)
18. Danese S., Mantovani A., Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer Oncogene 2010 29 23 3313 3323
19. Szlosarek P., Charles K. A., Balkwill F. R., Tumour necrosis factor- as a tumour promoter European Journal of Cancer 2006 42 6 745 750
20. Jones S. A., Directing transition from innate to acquired immunity: defining a role for IL-6 Journal of Immunology 2005 175 6 3463 3468 (Pubitemid 41292002)
21. Greten F. R., Eckmann L., Greten T. F., Park J. M., Li Z. W., Egan L. J., Kagnoff M. F., Karin M., IKK links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 2004 118 3 285 296 (Pubitemid 39061110)
22. Reinecker H. C., Loh E. Y., Ringler D. J., Mehta A., Rombeau J. L., MacDermott R. P., Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa Gastroenterology 1995 108 1 40 50
23. Mazzucchelli L., Hauser C., Zgraggen K., Wagner H. E., Hess M. W., Laissue J. A., Mueller C., Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease Journal of Pathology 1996 178 2 201 206 (Pubitemid 26057973)
24. Popivanova B. K., Kitamura K., Wu Y., Kondo T., Kagaya T., Kaneko S., Oshima M., Fuj C. II, Mukaida N., Blocking TNF- in mice reduces colorectal carcinogenesis associated with chronic colitis Journal of Clinical Investigation 2008 118 2 560 570 (Pubitemid 351206546)
25. Eurich K., Segawa M., Toei-Shimizu S., Mizoguchi E., Potential role of Chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells World Journal of Gastroenterology 2009 15 42 5249 5259
26. Segawa M., Zhang J., Eurich K., M1936 Chitinase 3-like-1 enhances inflammation-associated tumorigenesis by activating the -catenin/Wnt signaling pathway of CECs Gastroenterology 2010 138 5, Supplement 1 S-443
27. Boland C. R., Thibodeau S. N., Hamilton S. R., Sidransky D., Eshleman J. R., Burt R. W., Meltzer S. J., Rodriguez-Bigas M. A., Fodde R., Ranzani G. N., Srivastava S., A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Research 1998 58 22 5248 5257 (Pubitemid 28521189)
28. Itzkowitz S. H., Yio X., Inflammation and cancerIV. Colorectal cancer in inflammatory bowel disease: the role of inflammation American Journal of PhysiologyGastrointestinal and Liver Physiology 2004 287 1 G7 G17
29. Goel A., Arnold C. N., Niedzwiecki D., Chang D. K., Ricciardiello L., Carethers J. M., Dowell J. M., Wasserman L., Compton C., Mayer R. J., Bertagnolli M. M., Boland C. R., Characterization of sporadic colon cancer by patterns of genomic instability Cancer Research 2003 63 7 1608 1614 (Pubitemid 36373651)
30. Rowan A., Halford S., Gaasenbeek M., Kemp Z., Sieber O., Volikos E., Douglas E., Fiegler H., Carter N., Talbot I., Silver A., Tomlinson I., Refining molecular analysis in the pathways of colorectal carcinogenesis Clinical Gastroenterology and Hepatology 2005 3 11 1115 1123 (Pubitemid 41565378)
31. Weber J. C., Meyer N., Pencreach E., Schneider A., Gurin E., Neuville A., Stemmer C., Brigand C., Bachellier P., Rohr S., Kedinger M., Meyer C., Guenot D., Oudet P., Jaeck D., Gaub M. P., Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes International Journal of Cancer 2007 120 3 524 532 (Pubitemid 44969022)
32. Boveri T., Zur Frage der Entstehung Maligner Tumoren 1914 Jena, Germany Gustav Fischer
33. Herzog F., Primorac I., Dube P., Lenart P., Sander B., Mechtler K., Stark H., Peters J. M., Structure of the anaphase-promoting complex/cyclosome interacting with a mitotic checkpoint complex Science 2009 323 5920 1477 1481
34. Cahill D. P., Lengauer C., Yu J., Riggins G. J., Willson J. K. V., Markowitz S. D., Kinzler K. W., Vogelstein B., Mutations of mitotic checkpoint genes in human cancers Nature 1998 392 6673 300 303 (Pubitemid 28155105)
35. Wang Z., Cummins J. M., Shen D., Cahill D. P., Jallepalli P. V., Wang T. L., Parsons D. W., Traverso G., Awad M., Silliman N., Ptak J., Szabo S., Willson J. K. V., Markowitz S. D., Goldberg M. L., Karess R., Kinzler K. W., Vogelstein B., Velculescu V. E., Lengauer C., Three classes of genes mutated in colorectal cancers with chromosomal instability Cancer Research 2004 64 9 2998 3001 (Pubitemid 38581395)
36. Ganem N. J., Godinho S. A., Pellman D., A mechanism linking extra centrosomes to chromosomal instability Nature 2009 460 7252 278 282
37. Katayama H., Ota T., Jisaki F., Ueda Y., Tanaka T., Odashima S., Suzuki F., Terada Y., Tatsuka M., Mitotic kinase expression and colorectal cancer progression Journal of the National Cancer Institute 1999 91 13 1160 1162 (Pubitemid 29330556)
38. Macrek L., Lindqvist A., Lim D., Lampson M. A., Klompmaker R., Freire R., Clouin C., Taylor S. S., Yaffe M. B., Medema R. H., Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery Nature 2008 455 7209 119 123
39. Takahashi T., Sano B., Nagata T., Kato H., Sugiyama Y., Kunieda K., Kimura M., Okano Y., Saji S., Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers Cancer Science 2003 94 2 148 152 (Pubitemid 36575873)
40. Chen R., Rabinovitch P. S., Crispin D. A., Emond M. J., Bronner M. P., Brentnall T. A., The initiation of colon cancer in a chronic inflammatory setting Carcinogenesis 2005 26 9 1513 1519 (Pubitemid 41236044)
41. Sohn K. J., Shah S. A., Reid S., Choi M., Carrier J., Comiskey M., Terhorst C., Kim Y. I., Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and -microgiobulin-deficient mouse Cancer Research 2001 61 18 6912 6917 (Pubitemid 32896518)
42. Shattuck-Brandt R. L., Varilek G. W., Radhika A., Yang F., Washington M. K., DuBois R. N., Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice Gastroenterology 2000 118 2 337 345 (Pubitemid 30067507)
43. Erdman S. E., Poutahidis T., Tomczak M., Rogers A. B., Cormier K., Plank B., Horwitz B. H., Fox J. G., CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice American Journal of Pathology 2003 162 2 691 702 (Pubitemid 36267876)
44. Kado S., Uchida K., Funabashi H., Iwata S., Nagata Y., Ando M., Onoue M., Matsuoka Y., Ohwaki M., Morotomi M., Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor chain and p53 double-knockout mice Cancer Research 2001 61 6 2395 2398 (Pubitemid 32685812)
45. Chu F. F., Esworthy R. S., Chu P. G., Longmate J. A., Huycke M. M., Wilczynski S., Doroshow J. H., Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes Cancer Research 2004 64 3 962 968 (Pubitemid 38176898)
46. Rudolph U., Finegold M. J., Rich S. S., Harriman G. R., Srinivasan Y., Brabet P., Boulay G., Bradley A., Birnbaumer L., Ulcerative colitis and adenocarcinoma of the colon in G (i2)-deficient mice Nature Genetics 1995 10 2 143 150
47. Reitmair A. H., Redston M., Cai J. C., Chuang T. C. Y., Bjerknes M., Cheng H., Hay K., Gallinger S., Bapat B., Mak T. W., Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice Cancer Research 1996 56 16 3842 3849 (Pubitemid 26272038)
48. Edelmann W., Umar A., Yang K., Heyer J., Kucherlapati M., Lia M., Kneitz B., Avdievich E., Fan K., Wong E., Crouse G., Kunkel T., Lipkin M., Kolodner R. D., Kucherlapati R., The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression Cancer Research 2000 60 4 803 807 (Pubitemid 30129505)
49. Edelmann W., Yang K., Kuraguchi M., Heyer J., Lia M., Kneitz B., Fan K., Brown A. M. C., Lipkin M., Kucherlapati R., Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice Cancer Research 1999 59 6 1301 1307 (Pubitemid 29136262)
50. Chen P.-C., Dudley S., Hagen W., Dizon D., Paxton L., Reichow D., Yoon S.-R., Yang K., Arnheim N., Liskay R. M., Lipkin S. M., Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse Cancer Research 2005 65 19 8662 8670 (Pubitemid 41377353)
51. Lin D. P., Wang Y., Scherer S. J., Clark A. B., Yang K., Avdievich E., Jin BO., Werling U., Parris T., Kurihara N., Umar A., Kucherlapati R., Lipkin M., Kunkel T. A., Edelmann W., An Msh2 point mutation uncouples DNA mismatch repair and apoptosis Cancer Research 2004 64 2 517 522 (Pubitemid 38120890)
52. Avdievich E., Reiss C., Scherer S. J., Zhang Y., Maier S. M., Jin B., Hou H., Rosenwald A., Riedmiller H., Kucherlapati R., Cohen P. E., Edelmann W., Kneitz B., Distinct effects of the recurrent Mlh1 mutation on MMR functions, cancer, and meiosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 11 4247 4252 (Pubitemid 351754366)
53. Moser A. R., Luongo C., Gould K. A., McNeley M. K., Shoemaker A. R., Dove W. F., ApcMin: a mouse model for intestinal and mammary tumorigenesis European Journal of Cancer 1995 31 7-8 1061 1064
54. Half E., Bercovich D., Rozen P., Familial adenomatous polyposis Orphanet Journal of Rare Diseases 2009 4 1, article 22
55. McCart A. E., Vickaryous N. K., Silver A., Apc mice: models, modifiers and mutants Pathology Research and Practice 2008 204 7 479 490
56. Ritland S. R., Gendler S. J., Chemoprevention of intestinal adenomas in the Apc Min mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression Carcinogenesis 1999 20 1 51 58 (Pubitemid 29033844)
57. Fodde R., Smits R., Disease model: familial adenomatous polyposis Trends in Molecular Medicine 2001 7 8 369 373 (Pubitemid 32735023)
58. Moser A. R., Hegge L. F., Cardiff R. D., Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc Min /+ mice Cancer Research 2001 61 8 3480 3485 (Pubitemid 32695044)
59. Moser A. R., Shoemaker A. R., Connelly C. S., Clipson L., Gould K. A., Luongo C., Dove W. F., Siggers P. H., Gardner R. L., Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation Developmental Dynamics 1995 203 4 422 433
60. Alberici P., Fodde R., Volff J. N., The role of the APC tumor suppressor in chromosomal instability Genome and Disease 2006 1 Basel, Switzerland Karger 149 170 Genome Dynamics
61. Berg D. J., Davidson N., Khn R., Mller W., Menon S., Holland G., Thompson-Snipes L., Leach M. W., Rennick D., Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 + Th1-like responses Journal of Clinical Investigation 1996 98 4 1010 1020 (Pubitemid 26293320)
62. Sturlan S., Oberhuber G., Beinhauer B. G., Tichy B., Kappel S., Wang J., Rogy M. A., Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development Carcinogenesis 2001 22 4 665 671 (Pubitemid 32288669)
63. Kraus S., Arber N., Inflammation and colorectal cancer Current Opinion in Pharmacology 2009 9 4 405 410
64. Beatty P. L., Plevy S. E., Sepulveda A. R., Finn O. J., Cutting edge: transgenic expression of human MUC1 in IL-10 mice accelerates inflammatory bowel disease and progression to colon cancer Journal of Immunology 2007 179 2 735 739
65. Rennick D. M., Fort M. M., Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation American Journal of PhysiologyGastrointestinal and Liver Physiology 2000 278 6 G829 G833
66. Chichlowski M., Sharp J. M., Vanderford D. A., Myles M. H., Hale L. P., Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice Comparative Medicine 2008 58 6 534 541
67. Glauben R., Batra A., Stroh T., Erben U., Fedke I., Lehr H. A., Leoni F., Mascagni P., Dinarello C. A., Zeitz M., Siegmund B., Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice Gut 2008 57 5 613 622 (Pubitemid 351579973)
68. Nagamine C. M., Rogers A. B., Fox J. G., Schauer D. B., Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice International Journal of Cancer 2008 122 4 832 838
69. Neves S. R., Ram P. T., Iyengar R., G protein pathways Science 2002 296 5573 1636 1639 (Pubitemid 34579147)
70. Rudolphs U., Finegold M. J., Rich S. S., Harriman G. R., Srinivasan Y., Brabet P., Bradley A., Birnbaumer L., G(i2) protein deficiency: a model for inflammatory bowel disease Journal of Clinical Immunology 1995 15 6 101S 105S
71. Gordon F. H., Lai C. W. Y., Hamilton M. I., Allison M. C., Srivastava E. D., Fouweather M. G., Donoghue S., Greenlees C., Subhani J., Amlot P. L., Pounder R. E., A randomized placebo-controlled trial of a humanized monoclonal antibody to 4 integrin in active Crohn's disease Gastroenterology 2001 121 2 268 274 (Pubitemid 32729374)
72. Gordon F. H., Hamilton M. I., Donoghue S., Greenlees C., Palmer T., Rowley-Jones D., Dhillon A. P., Amlot P. L., Pounder R. E., A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin Alimentary Pharmacology and Therapeutics 2002 16 4 699 705 (Pubitemid 34407517)
73. Hesterberg P. E., Winsor-Hines D., Briskin M. J., Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta Gastroenterology 2001 121 268 274
74. Podolsky D. K., Lobb R., King N., Benjamin C. D., Pepinsky B., Sehgal P., DeBeaumont M., Attenuation of colitis in the cotton-top tamarin by anti- 4 integrin monoclonal antibody Journal of Clinical Investigation 1993 92 1 372 380 (Pubitemid 23209018)
75. Bjursten M., Bland P. W., Willn R., Hrnquist E. H., Long-term treatment with anti- 4 integrin antibodies aggravates colitis in G i2-deficient mice European Journal of Immunology 2005 35 8 2274 2283 (Pubitemid 41183691)
76. Clapp N. K., Henke M. L., Lushbaugh C. C., Humason G. L., Gangaware B. L., Effect of various biological factors on spontaneous marmoset and tamarin colitis. A retrospective histopathologic study Digestive Diseases and Sciences 1988 33 8 1013 1019
77. Saunders K. E., Shen Z., Dewhirst F. E., Paster B. J., Dangler C. A., Fox J. G., Novel intestinal Helicobacter species isolated from cotton-top tamarins (Saguinus oedipus) with chronic colitis Journal of Clinical Microbiology 1999 37 1 146 151 (Pubitemid 29004196)
78. Bertone E. R., Giovannucci E. L., King N. W., Petto A. J., Johnson L. D., Family history as a risk factor for ulcerative colitis-associated colon cancer in cotton-top tamarin Gastroenterology 1998 114 4 I 669 674 (Pubitemid 28160401)
79. Wood J. D., Peck O. C., Tefend K. S., Rodriguez-M M. A., Rodriguez-M J. V., Hernndez-C J. I., Stonerook M. J., Sharma H. M., Colitis and colon cancer in cotton-top tamarins (Saguinus oedipus oedipus) living wild in their natural habitat Digestive Diseases and Sciences 1998 43 7 1443 1453 (Pubitemid 28357261)
80. Mansfield K. G., Lin K. C., Xia D., Newman J. V., Schauer D. B., MacKey J., Lackner A. A., Carville A., Enteropathogenic Escherichia coli and ulcerative colitis in cotton-top tamarins (Saguinus oedipus) Journal of Infectious Diseases 2001 184 6 803 807 (Pubitemid 32826436)
81. Watkins P. E., Warren B. F., Stephens S., Ward P., Foulkes R., Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha Gut 1997 40 5 628 633 (Pubitemid 27278331)
82. Hanauer S. B., Feagan B. G., Lichtenstein G. R., Mayer L. F., Schreiber S., Colombel J. F., Rachmilewitz D., Wolf D. C., Olson A., Bao W., Rutgeerts P., Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 2002 359 9317 1541 1549 (Pubitemid 34621118)
83. Rutgeerts P., Diamond R. H., Bala M., Olson A., Lichtenstein G. R., Bao W., Patel K., Wolf D. C., Safdi M., Colombel J. F., Lashner B., Hanauer S. B., Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Gastrointestinal Endoscopy 2006 63 3 433 442 (Pubitemid 43261469)
84. Sands B. E., Anderson F. H., Bernstein C. N., Chey W. Y., Feagan B. G., Fedorak R. N., Kamm M. A., Korzenik J. R., Lashner B. A., Onken J. E., Rachmilewitz D., Rutgeerts P., Wild G., Wolf D. C., Marsters P. A., Travers S. B., Blank M. A., Van Deventer S. J., Infliximab maintenance therapy for fistulizing Crohn's disease New England Journal of Medicine 2004 350 9 876 885 (Pubitemid 38252535)
85. Ghosh S., Goldin E., Gordon F. H., Malchow H. A., Rask-Madsen J., Rutgeerts P., Vyhnlek P., Zdorov Z., Palmer T., Donoghue S., Natalizumab for active Crohn's disease New England Journal of Medicine 2003 348 1 24 32 (Pubitemid 36026343)
86. Sandborn W. J., Colombel J. F., Enns R., Feagan B. G., Hanauer S. B., Lawrance I. C., Panaccione R., Sanders M., Schreiber S., Targan S., Van Deventer S., Goldblum R., Despain D., Hogge G. S., Rutgeerts P., Natalizumab induction and maintenance therapy for Crohn's disease New England Journal of Medicine 2005 353 18 1912 1925 (Pubitemid 41565956)
87. van Assche G., van Ranst M., Sciot R., Dubois B., Vermeire S., Noman M., Verbeeck J., Geboes K., Robberecht W., Rutgeerts P., Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease New England Journal of Medicine 2005 353 4 362 368 (Pubitemid 41132340)
88. Podolsky D. K., Selective adhesion-molecule therapy and inflammatory bowel diseasea tale of Janus? New England Journal of Medicine 2005 353 18 1965 1968 (Pubitemid 41565962)
89. Ashi K. W., Inagaki T., Fujimoto Y., Fukuda Y., Induction by degraded carrageenan of colorectal tumors in rats Cancer Letters 1978 4 3 171 176 (Pubitemid 8318396)
90. Oohashi Y., Ishioka T., Wakabayashi K., Kuwabara N., A study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum Cancer Letters 1981 14 3 267 272 (Pubitemid 12223484)
91. Ishioka T., Kuwabara N., Oohashi Y., Wakabayashi K., Induction of colorectal tumors in rats by sulfated polysaccharides Critical Reviews in Toxicology 1987 17 3 215 244 (Pubitemid 17060266)
92. Tobacman J. K., Review of harmful gastrointestinal effects of carrageenan in animal experiments Environmental Health Perspectives 2001 109 10 983 994 (Pubitemid 33103729)
93. Benard C., Cultrone A., Michel C., Rosales C., Segain J.-P., Lahaye M., Galmiche J.-P., Cherbut C., Blotti Re H. M., Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF- B activation PLoS ONE 2010 5 1, article e8666
94. Chromik A. M., Mller A. M., Albrecht M., Rottmann S., Otte J. M., Herdegen T., Uhl W., Mittelktter U., Oral administration of Taurolidine ameliorates chronic DSS colitis in mice Journal of Investigative Surgery 2007 20 5 273 282 (Pubitemid 350048043)
95. Kim Y. J., Hong K. S., Chung J. W., Kim J. H., Hahm K. B., Prevention of colitis-associated carcinogenesis with infliximab Cancer Prevention Research 2010 3 10 1314 1333
96. Seril D. N., Liao J., Ho K. L. K., Warsi A., Yang C. S., Yang G. Y., Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice Digestive Diseases and Sciences 2002 47 6 1266 1278 (Pubitemid 34606629)
97. Okayasu I., Yamada M., Mikami T., Yoshida T., Kanno J., Ohkusa T., Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model Journal of Gastroenterology and Hepatology 2002 17 10 1078 1083 (Pubitemid 35013962)
98. Cooper H. S., Everley L., Chang W., Pfeiffer G., Lee B., Murthy S., Clapper M. L., The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis Gastroenterology 2001 121 6 1407 1416 (Pubitemid 33140458)
99. Kullmann F., Messmann H., Alt M., Gross V., Bocker T., Schlmerich J., Rschoff J., Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats International Journal of Colorectal Disease 2001 16 4 238 246 (Pubitemid 32700701)
100. Cooper H. S., Murthy S., Kido K., Yoshitake H., Flanigan A., Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation Carcinogenesis 2000 21 4 757 768 (Pubitemid 30214034)
101. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H., A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate Cancer Science 2003 94 11 965 973 (Pubitemid 37508979)
102. Rosenberg D. W., Giardina C., Tanaka T., Mouse models for the study of colon carcinogenesis Carcinogenesis 2009 30 2 183 196
103. Tanaka T., Yasui R., Preclinical animal studies on chemoprevention of colorectal cancer Clinical Gastroenterology 2008 23 1669 1676
104. Kohno H., Suzuki R., Sugie S., Tanaka T., -Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate Cancer Science 2005 96 2 69 76 (Pubitemid 40425381)
105. Tanaka T., Suzuki R., Kohno H., Sugie S., Takahashi M., Wakabayashi K., Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess -catenin gene mutations and increases immunoreactivity for -catenin, cyclooxygenase-2 and inducible nitric oxide synthase Carcinogenesis 2005 26 1 229 238 (Pubitemid 40207718)
106. Seril D. N., Liao J., Ho K. L. K., Yang C. S., Yang G. Y., Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine Carcinogenesis 2002 23 6 993 1001 (Pubitemid 34752955)
107. Seril D. N., Liao J., Yang G. Y., Yang C. S., Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis 2003 24 3 353 362 (Pubitemid 36432628)
108. Seril D. N., Liao J., West A. B., Yang G. Y., High-iron diet: Foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis Journal of Clinical Gastroenterology 2006 40 5 391 397 (Pubitemid 44318157)
109. Hardy R. G., Meltzer S. J., Jankowski J. A., ABC of colorectal cancer: molecular basis for risk factors British Medical Journal 2000 321 7265 886 889
110. Makiyama K., Takeshima F., Hamamoto T., Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report Digestive Diseases and Sciences 2005 50 12 2323 2329 (Pubitemid 43106387)
111. Tanaka T., Kohno H., Suzuki R., Hata K., Sugie S., Niho N., Sakano K., Takahashi M., Wakabayashi K., Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc Min /+ mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms International Journal of Cancer 2006 118 1 25 34 (Pubitemid 41681577)
112. Hussain S. P., Amstad P., Raja K., Ambs S., Nagashima M., Bennett W. P., Shields P. G., Ham A. J., Swenberg J. A., Marrogi A. J., Harris C. C., Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease Cancer Research 2000 60 13 3333 3337 (Pubitemid 30482141)
113. Burmer G. C., Crispin D. A., Kolli V. R., Haggitt R. C., Kulander B. G., Rubin C. E., Rabinovitch P. S., Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis Cancer Communications 1991 3 6 167 172
114. Chang W. C. I., Coudry R. A., Clapper M. I., Zhang X., Williams K. L., Spittle C. S., Li T., Cooper H. S., Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium Carcinogenesis 2007 28 11 2375 2381 (Pubitemid 350111597)
115. Fujii S., Fujimori T., Kawamata H., Takada J., Kitajima K., Omotehara F., Kaihara T., Kusaka T., Ichikawa K., Ohkura Y., Ono Y., Imura J., Yamaoka S., Sakamoto C., Ueda Y., Chiba T., Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium Gut 2004 53 5 710 716 (Pubitemid 38561450)
116. Wink D. A., Vodovotz Y., Laval J., Laval F., Dewhirst M. W., Mitchell J. B., The multifaceted roles of nitric oxide in cancer Carcinogenesis 1998 19 5 711 721 (Pubitemid 28376759)
117. Jaiswal M., LaRusso N. F., Gores G. J., Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis American Journal of PhysiologyGastrointestinal and Liver Physiology 2001 281 3 G626 G634
118. Seril D. N., Liao J., Yang G. Y., Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis Molecular Carcinogenesis 2007 46 5 341 353 (Pubitemid 46744454)
119. Fleisher A. S., Esteller M., Harpaz N., Leytin A., Rashid A., Xu Y., Liang J., Stine O. C., Yin J., Zou T. T., Abraham J. M., Kong D., Wilson K. T., James S. P., Herman J. G., Meltzer S. J., Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1 Cancer Research 2000 60 17 4864 4868
120. Cawkwell L., Sutherland F., Murgatroyd H., Jarvis P., Gray S., Cross D., Shepherd N., Day D., Quirke P., Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers Gut 2000 46 3 367 369 (Pubitemid 30313388)
121. Kohonen-Corish M. R. J., Daniel J. J., te Riele H., Buffinton G. D., Dahlstrom J. E., Susceptibility of Msh2-deficient mice to inflammation- associated colorectal tumors Cancer Research 2002 62 7 2092 2097 (Pubitemid 34408457)
122. Mizoguchi E., Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells Gastroenterology 2006 130 2 398 411 (Pubitemid 43202039)
123. Barrison I. G., Roberts P. D., Kane S. P., Oral or parenteral iron treatment in chronic ulcerative colitis? British Medical Journal 1981 282 6275 1514 (Pubitemid 11096566)
124. Ward J. M., Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats Laboratory Investigation 1974 30 4 505 513
125. DuBois R. N., Radhika A., Reddy B. S., Entingh A. J., Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 1996 110 4 1259 1262 (Pubitemid 26113767)
126. Guda K., Giardina C., Nambiar P., Cui H., Rosenberg D. W., Aberrant transforming growth factor- signaling in azoxymethane-induced mouse colon tumors Molecular Carcinogenesis 2001 31 4 204 213 (Pubitemid 32831346)
127. Relan N. K., Saeed A., Ponduri K., Fligiel S. E. G., Dutta S., Majumdar A. P. N., Identification and evaluation of the role of endogenous tyrosine kinases in azoxymethane induction of proliferative processes in the colonic mucosa of rats Biochimica et Biophysica Acta 1995 1244 2-3 368 376
128. Tanaka T., Colorectal carcinogenesis: review of human and experimental animal studies Journal of Carcinogenesis 2009 8, article 5
129. Uronis J. M., Mhlbauer M., Herfarth H. H., Rubinas T. C., Jones G. S., Jobin C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility PLoS ONE 2009 4 6, article e6026
130. Borthakur A., Bhattacharyya S., Dudeja P. K., Tobacman J. K., Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells American Journal of PhysiologyGastrointestinal and Liver Physiology 2007 292 3 G829 G838
131. Bhattacharyya S., Dudeja P. K., Tobacman J. K., Carrageenan-induced NF B activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10 Biochimica et Biophysica Acta 2008 1780 7-8 973 982
132. Wallach D., Varfolomeev E. E., Malinin N. L., Goltsev Y. V., Kovalenko A. V., Boldin M. P., Tumor necrosis factor receptor and Fas signaling mechanisms Annual Review of Immunology 1999 17 331 367 (Pubitemid 29241128)
133. Pimentel-Muios F. X., Seed B., Regulated commitment of TNF receptor signaling: a molecular switch for death or activation Immunity 1999 11 6 783 793 (Pubitemid 30030717)
134. Popivanova B. K., Kostadinova F. I., Furuichi K., Shamekh M. M., Kondo
135. Grivennikov S. I., Kuprash D. V., Liu Z., Nedospasov S. A., Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: from simple paradigms to complex mechanisms International Review of Cytology 2006 252 129 161 (Pubitemid 44375088)
136. Rutgeerts P., van Assche G., Vermeire S., Optimizing anti-TNF treatment in inflammatory bowel disease Gastroenterology 2004 126 6 1593 1610 (Pubitemid 38649876)
137. Peppel K., Crawford D., Beutler B., A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity Journal of Experimental Medicine 1991 174 6 1483 1489
138. Burstein E., Fearon E. R., Colitis and cancer: a tale of inflammatory cells and their cytokines Journal of Clinical Investigation 2008 118 2 464 467 (Pubitemid 351206535)
139. Bongartz T., Sutton A. J., Sweeting M. J., Buchan I., Matteson E. L., Montori V., Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials Journal of the American Medical Association 2006 295 19 2275 2285 (Pubitemid 43736578)
140. Biancone L., Petruzziello C., Calabrese E., Zorzi F., Naccarato P., Onali S., Pallone F., Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNF reduce colitis-associated colorectal carcinogenesis? Gut 2009 58 12, article 1703
141. Hoebe K., Janssen E., Beutler B., The interface between innate and adaptive immunity Nature Immunology 2004 5 10 971 974 (Pubitemid 41057712)
142. Heinrich P. C., Behrmann I., Muller-Newen G., Schaper F., Graeve L., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway Biochemical Journal 1998 334, part 2 297 314 (Pubitemid 28448572)
143. Veldhoen M., Hocking R. J., Atkins C. J., Locksley R. M., Stockinger B., TGF in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 2006 24 2 179 189 (Pubitemid 43214587)
144. Li M. O., Wan Y. Y., Flavell R. A., T cell-produced transforming growth factor- 1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation Immunity 2007 26 5 579 591 (Pubitemid 46756347)
145. Atreya R., Mudter J., Finotto S., Mllberg J., Jostock T., Wirtz S., Schtz M., Bartsch B., Holtmann M., Becker C., Strand D., Czaja J., Schlaak J. F., Lehr H. A., Autschbach F., Schrmann G., Nishimoto N., Yoshizaki K., Ito H., Kishimoto T., Galle P. R., Rose-John S., Neurath M. F., Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nature Medicine 2000 6 5 583 588 (Pubitemid 30305911)
146. Yamamoto M., Yoshizaki K., Kishimoto T., Ito H., IL-6 is required for the development of Th1 cell-mediated murine colitis Journal of Immunology 2000 164 9 4878 4882 (Pubitemid 30238092)
147. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., Mckenzie B., Kleinschek M. A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D. J., Kastelein R. A., Rennick D., IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 Journal of Clinical Investigation 2006 116 5 1310 1316
148. Noguchi M., Hiwatashi N., Liu Z., Toyota T., Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease Gut 1998 43 2 203 209 (Pubitemid 28348322)
149. Okayasu I., Yamada M., Mikami T., Yoshida T., Kanno J., Ohkusa T., Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model Journal of Gastroenterology and Hepatology 2002 17 10 1078 1083 (Pubitemid 35013962)
150. Mitsuyama K., Matsumoto S., Rose-John S., Suzuki A., Hara T., Tomiyasu N., Handa K., Tsuruta O., Funabashi H., Scheller J., Toyonaga A., Sata M., STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice Gut 2006 55 9 1263 1269 (Pubitemid 44277357)
151. Ito H., Takazoe M., Fukuda Y., Hibi T., Kusugami K., Andoh A., Matsumoto T., Yamamura T., Azuma J., Nishimoto N., Yoshizaki K., Shimoyama T., Kishimoto T., A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 2004 126 4 989 996 (Pubitemid 38451170)
152. Fenton J. I., Hursting S. D., Perkins S. N., Hord N. G., Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line Carcinogenesis 2006 27 7 1507 1515 (Pubitemid 43994862)
153. Becker C., Fantini M. C., Wirtz S., Nikolaev A., Lehr H. A., Galle P. R., Rose-John S., Neurath M. F., IL-6 signaling promotes tumor growth in colorectal cancer Cell Cycle 2005 4 2 217 220 (Pubitemid 41365319)
154. Chung Y. C., Chang Y. F., Serum interleukin-6 levels reflect the disease status of colorectal cancer Journal of Surgical Oncology 2003 83 4 222 226
155. Yu H., Pardoll D., Jove R., STATs in cancer inflammation and immunity: a leading role for STAT3 Nature Reviews Cancer 2009 9 11 798 809
156. Bollrath J., Phesse T. J., von Burstin V. A., Putoczki T., Bennecke M., Bateman T., Nebelsiek T., Lundgren-May T., Canli., Schwitalla S., Matthews V., Schmid R. M., Kirchner T., Arkan M. C., Ernst M., Greten F. R., gp130-mediated stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis Cancer Cell 2009 15 2 91 102
157. Atreya R., Neurath M. F., Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer Clinical Reviews in Allergy and Immunology 2005 28 3 187 195 (Pubitemid 41208908)
158. Naugler W. E., Karin M., The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer Trends in Molecular Medicine 2008 14 3 109 119
159. Becker C., Fantini M. C., Schramm C., Lehr H. A., Wirtz S., Nikolaev A., Burg J., Strand S., Kiesslich R., Huber S., Ito H., Nishimoto N., Yoshizaki K., Kishimoto T., Galle P. R., Blessing M., Rose-John S., Neurath M. F., TGF- suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 2004 21 4 491 501 (Pubitemid 39370505)
160. Li YI., de Haar C., Chen M., Deuring J., Gerrits M. M., Smits R., Xia B., Kuipers E. J., Van Janneke Der Woude C., Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis Gut 2010 59 2 227 235
161. Lankford C. S. R., Frucht D. M., A unique role for IL-23 in promoting cellular immunity Journal of Leukocyte Biology 2003 73 1 49 56 (Pubitemid 36125674)
162. Abraham C., Cho J. H., IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease Annual Review of Medicine 2009 60 97 110
163. Ahern P. P., Izcue A., Maloy K. J., Powrie F., The interleukin-23 axis in intestinal inflammation Immunological Reviews 2008 226 1 147 159
164. Langowski J. L., Zhang X., Wu L., Mattson J. D., Chen T., Smith K., Basham B., McClanahan T., Kastelein R. A., Oft M., IL-23 promotes tumour incidence and growth Nature 2006 442 7101 461 465 (Pubitemid 44264796)
165. Shan B. E., Hao J. S., Li Q. X., Tagawa M., Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells Cellular amp; Molecular Immunology 2006 3 1 47 52
166. Shen W., Durum S. K., Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease Neurochemical Research 2010 35 6 940 946
167. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., Taketo M., Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene Proceedings of the National Academy of Sciences of the United States of America 1995 92 10 4482 4486
168. Fukata M., Chen A., Klepper A., Krishnareddy S., Vamadevan A. S., Thomas L. S., Xu R., Inoue H., Arditi M., Dannenberg A. J., Abreu M. T., Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine Gastroenterology 2006 131 3 862 877 (Pubitemid 44316821)
169. Hernandez Y., Sotolongo J., Breglio K., Conduah D., Chen A., Xu R., Hsu D., Ungaro R., Hayes L. A., Pastorini C., Abreu M. T., Fukata M., The role of prostaglandin E2(PGE 2) in Toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia BMC Gastroenterology 2010 10, article 82
170. Taketo M. M., COX-2 and colon cancer Inflammation Research 1998 47 2 S112 S116
171. Mukawa K., Fujii S., Tominaga K., Yoshitake N., Abe A., Kono T., Sekikawa A., Fukui H., Ichikawa K., Tomita S., Imura J., Ono Y., Shinoda M., Hiraishi H., Fujimori T., Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium Oncology Reports 2008 19 2 393 399 (Pubitemid 351176099)
172. Grubbs C. J., Lubet R. A., Koki A. T., Leahy K. M., Masferrer J. L., Steele V. E., Kelloff G. J., Hill D. L., Seibert K., Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats Cancer Research 2000 60 20 5599 5602
173. Basu G. D., Pathangey L. B., Tinder T. L., Gendler S. J., Mukherjee P., Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells Breast Cancer Research 2005 7 4 R422 435
174. Lin J., Hsiao P. W., Chiu T. H., Chao J. I., Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells Biochemical Pharmacology 2005 70 5 658 667 (Pubitemid 41058700)
175. Haynes A., Shaik M. S., Chatterjee A., Singh M., Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer Pharmaceutical Research 2005 22 3 427 439 (Pubitemid 40558502)
176. Solomon S. D., Pfeffer M. A., McMurray J. J. V., Fowler R., Finn P., Levin B., Eagle C., Hawk E., Lechuga M., Zauber A. G., Bertagnolli M. M., Arber N., Wittes J., Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas Circulation 2006 114 10 1028 1035 (Pubitemid 44358879)
177. Solomon S. D., Wittes J., Finn P. V., Fowler R., Viner J., Bertagnolli M. M., Arber N., Levin B., Meinert C. L., Martin B., Pater J. L., Goss P. E., Lance P., Obara S., Chew E. Y., Kim J., Arndt G., Hawk E., Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Circulation 2008 117 16 2104 2113 (Pubitemid 351572169)
178. Bosetti C., Gallus S., La Vecchia C., Aspirin and cancer risk: an update to 2001 European Journal of Cancer Prevention 2002 11 6 535 542 (Pubitemid 35430657)
179. Baron J. A., Cole B. F., Sander R. S., A randomized trial of aspirin to prevent colorectal adenomas. A randomized trial od aspirin to prevent colorectal adenomas New England Journal of Medicine 2003 40 289 292
180. Sandler R. S., Halabi S., Baron J. A., Budinger S., Paskett E., Keresztes R., Petrelli N., Pipas J. M., Karp D. D., Loprinzi C. L., Steinbach G., Schilsky R., A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer New England Journal of Medicine 2003 348 10 883 890 (Pubitemid 36297996)
181. Craven P. A., DeRubertis F. R., Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis Carcinogenesis 1992 13 4 541 546
182. Reddy B. S., Rao C. V., Rivenson A., Kelloff G., Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 1993 14 8 1493 1497 (Pubitemid 23249348)
183. Mahmoud N. N., Dannenberg A. J., Mestre J., Bilinski R. T., Churchill M. R., Martucci C., Newmark H., Bertagnolli M. M., Townsend C. M. Jr., Beauchamp R. D., Aspirin prevents tumors in a murine model of familial adenomatous polyposis Surgery 1998 124 2 225 231 (Pubitemid 28372920)
184. Paterson J., Baxter G., Lawrence J., Duthie G., Is there a role for dietary salicylates in health? Proceedings of the Nutrition Society 2006 65 1 93 96 (Pubitemid 43259988)
185. Pestka S., Krause C. D., Sarkar D., Walter M. R., Shi Y., Fisher P. B., Interleukin-10 and related cytokines and receptors Annual Review of Immunology 2004 22 929 979 (Pubitemid 38680445)
186. Ho A. S., Wei S. H., Mui A. L., Miyajima A., Moore K. W., Functional regions of the mouse interleukin-10 receptor expression on human natural killer cells Blood 1995 85 3577 3585
187. Kuhn R., Lohler J., Rennick D., Rajewski K., Muller W., Interleukin-10-deficient mice develop chronic colonic enterocolitis Cell 1993 75 263 274 (Pubitemid 23320290)
188. Stetler-Stevenson W. G., Aznavoorian S., Liotta L. A., Tumor cell interactions with the extracellular matrix during invasion and metastasis Annual Review of Cell Biology 1993 9 541 573
189. Khalil N., TGF- : from latent to active Microbes and Infection 1999 1 15 1255 1263
190. Fantini M. C., Becker C., Monteleone G., Pallone F., Galle P. R., Neurath M. F., Cutting edge: TGF- induces a regulatory phenotype in CD4 +CD25- T cells through Foxp3 induction and down-regulation of Smad7 Journal of Immunology 2004 172 9 5149 5153 (Pubitemid 38542009)
191. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70 (Pubitemid 30046295)
192. Blobe G. C., Schiemann W. P., Lodish H. F., Role of transforming growth factor in human disease New England Journal of Medicine 2000 342 18 1350 1358 (Pubitemid 30408720)
193. Engle S. J., Ormsby I., Pawlowski S., Boivin G. P., Croft J., Balish E., Doetschman T., Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice Cancer Research 2002 62 22 6362 6366 (Pubitemid 35364086)
194. Leroith D., Roberts C. T., Insulin-like growth factors Annals of the New York Academy of Sciences 1993 692 1 9 (Pubitemid 23299511)
195. Germs D., Partridge L., Insulin/IGF signaling and ageing:seeing the bigger picture Current Opinion in Genetics Development 2001 11 287 292 (Pubitemid 32480295)
196. Foulstone E., Prince S., Zaccheo O., Burns J. L., Harper J., Jacobs C., Church D., Hassan A. B., Insulin-like growth factor ligands, receptors, and binding proteins in cancer Journal of Pathology 2005 205 2 145 153 (Pubitemid 40227987)
197. Feinberg A. P., Tycko B., The history of cancer epigenetics Nature Reviews Cancer 2004 4 2 143 153 (Pubitemid 38198742)
198. Cui H., Onyango P., Brandenburg S., Wu Y., Hsieh C. L., Feinberg A. P., Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2 Cancer Research 2002 62 22 6442 6446 (Pubitemid 35364103)
199. Cui H., Cruz-Correa M., Giardiello F. M., Hutcheon D. F., Kafonek D. R., Brandenburg S., Wu Y., He X., Powe N. R., Feinberg A. P., Loss of IGF2 imprinting: a potential marker of colorectal cancer risk Science 2003 299 5613 1753 1755 (Pubitemid 36337205)
200. Sakatani T., Kaneda A., Iacobuzio-Donahue C. A., Carter M. G., De Boom Witzel S., Okano H., Ko M. S. H., Ohlsson R., Longo D. L., Feinberg A. P., Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice Science 2005 307 5717 1976 1978 (Pubitemid 40404709)
201. Kaneda A., Wang C. J., Cheong R., Timp W., Onyango P., Wen B., Iacobuzio-Donahue C. A., Ohlsson R., Andraos R., Pearson M. A., Sharov A. A., Longo D. L., Ko M. S.H., Levchenko A., Feinberg A. P., Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk Proceedings of the National Academy of Sciences of the United States of America 2007 104 52 20926 20931
202. Maloney E. K., McLaughlin J. L., Dagdigian N. E., Garrett L. M., Connors K. M., Zhou X. M., Blttler W. A., Chittenden T., Singh R., An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation Cancer Research 2003 63 16 5073 5083 (Pubitemid 37022647)
203. Mitsiades C. S., Mitsiades N. S., McMullan C. J., Poulaki V., Shringarpure R., Akiyama M., Hideshima T., Chauhan D., Joseph M., Libermann T. A., Garca-Echeverra C., Pearson M. A., Hofmann F., Anderson K. C., Kung A. L., Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors Cancer Cell 2004 5 3 221 230 (Pubitemid 38402114)
204. Carpenter G., Cohen S., Epidermal growth factor Journal of Biological Chemistry 1990 265 14 7709 7712 (Pubitemid 20158927)
205. Cawkwell L., Sutherland F., Murgatroyd H., Jarvis P., Gray S., Cross D., Shepherd N., Day D., Quirke P., Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers Gut 2000 46 3 367 369 (Pubitemid 30313388)
206. Herbst R. S., Review of epidermal growth factor receptor biology International Journal of Radiation Oncology Biology Physics 2004 59 2 21 26 (Pubitemid 38610223)
207. Sinha A., Nightingale J., West K. P., Berlanga-Acosta J., Playford R. J., Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis New England Journal of Medicine 2003 349 4 350 357 (Pubitemid 36886241)
208. Bashir O., Fitzgerald A. J., Berlanga-Acosta J., Playford R. J., Goodlad R. A., Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice Clinical Science 2003 105 3 323 330 (Pubitemid 37088571)
209. Fichera A., Little N., Jagadeeswaran S., Dougherty U., Sehdev A., Mustafi R., Cerda S., Yuan W., Khare S., Tretiakova M., Gong C., Tallerico M., Cohen G., Joseph L., Hart J., Turner J. R., Bissonnette M., Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis Cancer Research 2007 67 2 827 835 (Pubitemid 46192224)
210. Hu T., Li C., Convergence between Wnt- -catenin and EGFR signaling in cancer Molecular Cancer 2010 9 236 242
211. Park J.-A., Drazen J. M., Tschumperlin D. J., The Chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress Journal of Biological Chemistry 2010 285 39 29817 29825
212. Shao R., Hamel K., Petersen L., Cao Q. J., Arenas R. B., Bigelow C., Bentley B., Yan W., YKL-40, a secreted glycoprotein, promotes tumor angiogenesis Oncogene 2009 28 50 4456 4468
213. Cohen G., Mustafi R., Chumsangsri A., Little N., Nathanson J., Cerda S., Jagadeeswaran S., Dougherty U., Joseph L., Hart J., Yerian L., Tretiakova M., Yuan W., Obara P., Khare S., Sinicrope F. A., Fichera A., Boss G. R., Carroll R., Bissonnette M., Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci Cancer Research 2006 66 11 5656 5664 (Pubitemid 43927118)
214. Liu Y., Ju J., Xiao H., Simi B., Hao X., Reddy B. S., Huang M. T., Newmark H., Yang C. S., Effects of combination of calcium and aspirin on azoxymethane-induced aberrant crypt foci formation in the colons of mice and rats Nutrition and Cancer 2008 60 5 660 665
215. Wargovich M. J., Allnutt D., Palmer C., Anaya P., Stephens L. C., Inhibition of the promotional phase of azoxymethane-induced colon carcinogenesis in the F344 rat by calcium lactate: effect of simulating two human nutrient density levels Cancer Letters 1990 53 1 17 25 (Pubitemid 20279379)
216. Wargovich M. J., Lynch P. M., Levin B., Modulating effects of calcium in animal models of colon carcinogenesis and short-term studies in subjects at increased risk for colon cancer American Journal of Clinical Nutrition 1991 54 1 202S 205S
217. McCullough M. L., Robertson A. S., Rodriguez C., Jacobs E. J., Chao A., Jonas C., Calle E. E., Willett W. C., Thun M. J., Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States) Cancer Causes and Control 2003 14 1 1 12 (Pubitemid 36403263)
218. Wu K., Willett W. C., Fuchs C. S., Colditz G. A., Giovannucci E. L., Calcium intake and risk of colon cancer in women and men Journal of the National Cancer Institute 2002 94 6 437 446 (Pubitemid 34285093)
219. Terry P., Baron J. A., Bergkvist L., Holmberg L., Wolk A., Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women Nutrition and Cancer 2002 43 1 39 46 (Pubitemid 35387254)
220. Park Y., Leitzmann M. F., Subar A. F., Hollenbeck A., Schatzkin A., Dairy food, calcium, and risk of cancer in the NIH-AARP diet and health study Archives of Internal Medicine 2009 169 4 391 401
221. Lamprecht S. A., Lipkin M., Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis Annals of the New York Academy of Sciences 2001 952 73 87 (Pubitemid 34060011)
222. Fernandez E. J., Lolis E., Structure, function, and inhibition of chemokines Annual Review of Pharmacology and Toxicology 2002 42 469 499 (Pubitemid 34160533)
223. Wang H., Czura C., Tracey K., Thomson A., Lotze M., TNF The Cytokine Handbook 2003 London, UK Elsevier Science 837 860
224. Garlanda C., Riva F., Veliz T., Polentarutti N., Pasqualini F., Radaelli E., Sironi M., Nebuloni M., Zorini E. O., Scanziani E., Mantovani A., Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family Cancer Research 2007 67 13 6017 6021 (Pubitemid 47037479)
225. Wang D., Wang H., Brown J., Daikoku T., Ning W., Shi Q., Richmond A., Strieter R., Dey S. K., DuBois R. N., CXCL1 induced by prostaglandin E promotes angiogenesis in colorectal cancer Journal of Experimental Medicine 2006 203 4 941 951
226. Sakamoto K., Maeda S., Targeting NF- B for colorectal cancer Expert Opinion on Therapeutic Targets 2010 14 6 593 601
227. Nibbs R. J. B., Kriehuber E., Ponath P. D., Parent D., Qin S., Campbell J. D. M., Henderson A., Kerjaschki D., Maurer D., Graham G. J., Rot A., The -chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors American Journal of Pathology 2001 158 3 867 877 (Pubitemid 32221780)
228. Shahabuddin M., Toyoshima T., Aikawa M., Kaslow D. C., Transmission-blocking activity of a Chitinase inhibitor and activation of malarial parasite Chitinase by mosquito protease Proceedings of the National Academy of Sciences of the United States of America 1993 90 9 4266 4270 (Pubitemid 23134207)
229. Henrissat B., Davies G., Structural and sequence-based classification of glycoside hydrolases Current Opinion in Structural Biology 1997 7 5 637 644 (Pubitemid 27472582)
230. Hakala B. E., White C., Recklies A. D., Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a Mammalian member of a Chitinase protein family Journal of Biological Chemistry 1993 268 34 25803 25810 (Pubitemid 23358198)
231. Boot R. G., Blommaart E. F. C., Swart E., Ghauharali-van der Vlugt K., Bijl N., Moe C., Place A., Aerts J. M. F. G., Identification of a novel acidic Mammalian Chitinase distinct from chitotriosidase Journal of Biological Chemistry 2001 276 9 6770 6778
232. Hollak C. E. M., van Weely S., van Oers M. H. J., Aerts J. M. F. G., Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease Journal of Clinical Investigation 1994 93 3 1288 1292
233. Jin H. M., Copeland N. G., Gilbert D. J., Jenkins N. A., Kirkpatrick R. B., Rosenberg M., Genetic characterization of the murine Ym1 gene and identification of a cluster of highly homologous genes Genomics 1998 54 2 316 322 (Pubitemid 28553641)
234. Vind I., Johansen J. S., Price P. A., Munkholm P., Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease Scandinavian Journal of Gastroenterology 2003 38 6 599 605 (Pubitemid 36724038)
235. Cintin C., Johansen J. S., Christensen I. J., Price P. A., Srensen S., Nielsen H. J., High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival Cancer 2002 95 2 267 274 (Pubitemid 34787591)
236. Johansen J. S., Jensen B. V., Roslind A., Nielsen D., Price P. A., Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiology Biomarkers and Prevention 2006 15 2 194 202 (Pubitemid 43342164)
237. Johansen J. S., Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer Danish Medical Bulletin 2006 53 2 172 209 (Pubitemid 43772025)
238. Bigg H. F., Wait R., Rowan A. D., Cawston T. E., The Mammalian Chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation Journal of Biological Chemistry 2006 281 30 21082 21095 (Pubitemid 44115449)
239. Fusetti F., Pijning T., Kalk K. H., Bos E., Dijkstra B. W., Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39 Journal of Biological Chemistry 2003 278 39 37753 37760 (Pubitemid 37175301)
240. Park J. A., Drazen J. M., Tschumperlin D. J., The Chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress Journal of Biological Chemistry 2010 285 39 29817 2982